Diabetes, Vol 37, Issue 9 1157-1162, Copyright © 1988 by American Diabetes Association

ARTICLES

Galanin--sympathetic neurotransmitter in endocrine pancreas?

BE Dunning and GJ Taborsky
Department of Medicine, University of Washington, Seattle.

The effects of sympathetic neural activation on basal pancreatic hormone secretion cannot be explained solely by the actions of the classic sympathetic neurotransmitter norepinephrine. The nonadrenergic component may be mediated by the 29-amino acid peptide galanin in that this neuropeptide meets several of the criteria necessary to be considered a sympathetic neurotransmitter in the endocrine pancreas. 1) Galanin administration inhibits basal insulin and somatostatin secretion and stimulates basal glucagon secretion from the pancreas, qualitatively reproducing the effects of sympathetic nerve stimulation. These sympathomimetic effects appear to be mediated by direct actions of galanin on the islet. 2) Galanin-like immunoreactivity exists in fibers that innervate pancreatic islets. 3) Galanin is released during electrical stimulation of pancreatic nerves. The quantity released is sufficient to reproduce sympathetic nerve stimulation-induced effects on insulin secretion and to contribute to the neural effects on somatostatin and glucagon release. 4) Whether interference with galanin action or release reduces the islet response to sympathetic nerve stimulation remains to be determined. We hypothesize that galanin and norepinephrine act together to mediate the islet response to sympathetic neural activation. If galanin is a sympathetic neurotransmitter in the endocrine pancreas, it may contribute to the inhibition of insulin secretion that occurs during stress and thereby to the hyperglycemic response. Moreover, the local presence of this potent beta-cell inhibitor in the islet leads to speculation on galanin's contribution to the impairment of insulin secretion that occurs in non-insulin-dependent diabetes mellitus and therefore on the potential utility of a galanin antagonist in the treatment of this disease.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. D. Palmer, C. D. Langefeld, J. K. Campbell, A. H. Williams, M. Saad, J. M. Norris, S. M. Haffner, J. I. Rotter, L. E. Wagenknecht, R. N. Bergman, et al. Genetic Mapping of Disposition Index and Acute Insulin Response Loci on Chromosome 11q: The Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes, April 1, 2006; 55(4): 911 - 918. [Abstract] [Full Text] [PDF]

				P. Gilon and J.-C. Henquin Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic {beta}-Cell Function Endocr. Rev., October 1, 2001; 22(5): 565 - 604. [Abstract] [Full Text] [PDF]

				F. C. Schuit, P. Huypens, H. Heimberg, and D. G. Pipeleers Glucose Sensing in Pancreatic {beta}-Cells: A Model for the Study of Other Glucose-Regulated Cells in Gut, Pancreas, and Hypothalamus Diabetes, January 1, 2001; 50(1): 1 - 11. [Abstract] [Full Text]

				R. H. Coker, Y. Koyama, D. B. Lacy, P. E. Williams, N. Rheaume, and D. H. Wasserman Pancreatic innervation is not essential for exercise-induced changes in glucagon and insulin or glucose kinetics Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1122 - E1129. [Abstract] [Full Text] [PDF]

				E. Ferrannini Insulin Resistance versus Insulin Deficiency in Non-Insulin-Dependent Diabetes Mellitus: Problems and Prospects Endocr. Rev., August 1, 1998; 19(4): 477 - 490. [Abstract] [Full Text] [PDF]

				T. O. Mundinger, C. B. Verchere, D. G. Baskin, M. R. Boyle, S. Kowalyk, and G. J. Taborsky Jr. Galanin is localized in sympathetic neurons of the dog liver Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1194 - E1202. [Abstract] [Full Text] [PDF]